Related Experiment Videos
Multicriteria decision analysis in oncology
Georges Adunlin1, Vakaramoko Diaby1, Alberto J Montero2
1Division of Economic, Social and Administrative Pharmacy, College of Pharmacy and Pharmaceutical Sciences, Florida A&M University, Tallahassee, FL, USA.
Summary
Multicriteria decision analysis (MCDA) can aid oncology clinical decision-making by analyzing trade-offs. Further field testing is recommended before widespread adoption of this promising tool.
Area of Science:
- Healthcare Decision Science
- Oncology Research
- Clinical Decision Support
Background:
- Growing interest in alternative decision-making frameworks in healthcare.
- Multicriteria Decision Analysis (MCDA) is an emerging framework.
- Limited application of MCDA in oncology research.
Purpose of the Study:
- Discuss the rationale for using MCDA in oncology.
- Explore how MCDA can develop clinical decision support tools for oncology.
Main Methods:
- Overview of MCDA methods and processes.
- Discussion of MCDA applications.
- Illustrative example of MCDA in oncology.
Main Results:
- MCDA helps analyze trade-offs between benefits and harms in oncology.
- Eight studies were reviewed, with the Analytical Hierarchy Process (AHP) being the most common method.
- Method selection depends on data source and nature.
Conclusions:
- MCDA shows promise as a clinical decision-making tool in oncology.
- Field testing is necessary before establishing MCDA as a standard tool.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
01:20Comparing the Survival Analysis of Two or More Groups
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...